ATE227128T1 - Niacin enthaltende tabletten und sätze mit verzögerter wirkstoffabgabe - Google Patents
Niacin enthaltende tabletten und sätze mit verzögerter wirkstoffabgabeInfo
- Publication number
- ATE227128T1 ATE227128T1 AT93401681T AT93401681T ATE227128T1 AT E227128 T1 ATE227128 T1 AT E227128T1 AT 93401681 T AT93401681 T AT 93401681T AT 93401681 T AT93401681 T AT 93401681T AT E227128 T1 ATE227128 T1 AT E227128T1
- Authority
- AT
- Austria
- Prior art keywords
- sustained
- release tablets
- sets containing
- containing niacin
- niacin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/905,785 US5268181A (en) | 1989-04-13 | 1992-06-29 | Method of using niacin to control nocturnal cholesterol synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE227128T1 true ATE227128T1 (de) | 2002-11-15 |
Family
ID=25421462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93401681T ATE227128T1 (de) | 1992-06-29 | 1993-06-29 | Niacin enthaltende tabletten und sätze mit verzögerter wirkstoffabgabe |
Country Status (7)
Country | Link |
---|---|
US (1) | US5268181A (de) |
EP (3) | EP0577504B1 (de) |
AT (1) | ATE227128T1 (de) |
DE (1) | DE69332463T2 (de) |
DK (1) | DK0577504T3 (de) |
ES (1) | ES2186674T3 (de) |
PT (1) | PT577504E (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721221A (en) * | 1991-03-08 | 1998-02-24 | Regents Of The University Of Minnesota | Lowering blood cholesterol levels using water soluble cellulose ethers |
DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
EP0643965B1 (de) * | 1993-09-20 | 2013-05-08 | Abbott Laboratories | Nicotinsäure enthaltende Zusammensetzungen zur Behandlung der Hyperlipidämie |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US20080045573A1 (en) * | 1993-09-20 | 2008-02-21 | Bova David J | Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia |
US6406715B1 (en) * | 1993-09-20 | 2002-06-18 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles |
US6746691B2 (en) * | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US20060263428A1 (en) * | 1993-09-20 | 2006-11-23 | Eugenio Cefali | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6676967B1 (en) * | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
EP0821587A4 (de) * | 1995-04-19 | 1999-05-19 | Lipoprotein Technologies Inc | Mittel, kits und verfahren zur verabreichung von antilipämischen und gegen die blutplättchen-aggregation wirkenden arzneistoffen |
ES2191706T3 (es) * | 1995-06-07 | 2003-09-16 | Pfizer | Derivados de tetrahidro-isoquinolinil-6-il amida del acido bifenil-2-carboxilico, su preparacion y su uso como inhibidores de la proteina de transferencia de trigliceridos microsomal y/o secrecion de apolipoproteina b (apo b). |
US7179486B1 (en) * | 1997-04-01 | 2007-02-20 | Nostrum Pharmaceuticals, Inc. | Process for preparing sustained release tablets |
PT1017390E (pt) * | 1997-07-31 | 2007-07-24 | Kos Life Sciences Inc | Comprimido revestido que compreende ácido nicotínico ou um composto metabolizado a ácido nicotínico sob uma forma de libertação prolongada, e um revestimento que contém um inibidor da hmg-coa-redutase sob uma forma de libertação imediata. |
US20010006644A1 (en) | 1997-07-31 | 2001-07-05 | David J. Bova | Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night |
US6469035B1 (en) * | 1997-07-31 | 2002-10-22 | Eugenio A. Cefali | Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
UA77660C2 (en) * | 2000-10-03 | 2007-01-15 | Compositions and methods for reducing plasma lipoprotein a level in human | |
US7052706B2 (en) * | 2001-06-08 | 2006-05-30 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
AU2005305086A1 (en) * | 2004-11-05 | 2006-05-18 | Arena Pharmaceuticals, Inc. | Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
WO2006048895A1 (en) * | 2004-11-08 | 2006-05-11 | Rubicon Research Pvt. Ltd. | Aqueous pharmaceutical coating |
FR2878748B1 (fr) * | 2004-12-07 | 2007-03-09 | Arrow Generiques Soc Par Actio | Formule de comprimes permettant une liberation prolongee d'indapamide apres administration par voie orale et procede de preparation |
AU2006214286A1 (en) * | 2005-02-18 | 2006-08-24 | Arena Pharmaceuticals, Inc. | Methods and compositions for the treatment of lipid-associated disorders |
US20070053930A1 (en) * | 2005-09-07 | 2007-03-08 | Bebaas, Inc. | Combination therapy for treatment of high cholesterol |
CA2569776A1 (en) * | 2006-02-17 | 2007-08-17 | Kos Life Sciences, Inc. | Low flush niacin formulation |
WO2008100249A1 (en) * | 2007-02-13 | 2008-08-21 | Kos Life Sciences, Inc. | Low flush niacin formulation |
EP2114151A4 (de) * | 2007-03-01 | 2010-03-17 | Concourse Health Sciences Llc | Isomere von inositol-niacinat und anwendungen davon |
AR065670A1 (es) | 2007-03-09 | 2009-06-24 | Indigene Pharmaceuticals Inc | Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas |
KR100836960B1 (ko) * | 2007-09-07 | 2008-06-10 | 주식회사 서울제약 | 새로운 나이아신 제어방출형 제제 |
EP2296709A4 (de) * | 2008-06-02 | 2012-02-01 | Reddys Lab Ltd Dr | Niacinformulierungen mit modifizierter freisetzung |
WO2010010579A1 (en) * | 2008-07-19 | 2010-01-28 | Lupin Limited | Multiple unit dosage form of niacin |
WO2013052117A1 (en) | 2011-10-05 | 2013-04-11 | Golini Jeffrey M | Choline composition |
US20140113939A1 (en) * | 2012-10-22 | 2014-04-24 | Abbott Laboratories | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
JPS5031022A (de) * | 1973-05-29 | 1975-03-27 | ||
US4166902A (en) * | 1974-10-14 | 1979-09-04 | Paolo Ferruti | High polymers containing nicotinic acid, process for their preparation and their use |
US4568547A (en) * | 1979-08-30 | 1986-02-04 | Herschler R J | Solid pharmaceutical compositions comprising MSM and their production |
US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4457907A (en) * | 1982-08-05 | 1984-07-03 | Clear Lake Development Group | Composition and method for protecting a therapeutic drug |
FR2535202B1 (fr) * | 1982-11-03 | 1985-08-09 | Fabre Sa Pierre | Comprimes de theophylline a liberation controlee et leur procede de fabrication |
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
NL8600050A (nl) * | 1986-01-13 | 1987-08-03 | Sanico Nv | Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van. |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4795642A (en) * | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
US4752479A (en) * | 1986-05-27 | 1988-06-21 | Ciba-Geigy Corporaton | Multi vitamin and mineral dietary supplement with controlled release bioavailable iron |
US5110940A (en) * | 1987-02-25 | 1992-05-05 | Bristol-Myers Company | Antihypercholesterolemic tetrazole compounds |
US4950689A (en) * | 1987-03-31 | 1990-08-21 | Yang Robert K | Pectin delivery system |
JPS63310827A (ja) * | 1987-06-15 | 1988-12-19 | Sanwa Kagaku Kenkyusho Co Ltd | ニコチン酸誘導体を主剤とする徐放性製剤 |
US4965252A (en) * | 1988-06-28 | 1990-10-23 | Hauser-Kuhrts, Inc. | Cholesterol-lowering combination compositions of guar gum and niacin |
US5023245A (en) * | 1987-11-10 | 1991-06-11 | Hauser-Kuhrts, Inc. | Improved niacin formulation |
US4911917A (en) * | 1988-06-28 | 1990-03-27 | Hauser-Kuhrts, Inc. | Cholesterol-lowering combination comopsitions of magnesium salt and niacin |
US5116610A (en) * | 1987-12-29 | 1992-05-26 | The Procter & Gamble Company | Compositions for treating hypercholesterolemia |
US5030653A (en) * | 1988-03-30 | 1991-07-09 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
US5049696A (en) * | 1988-04-11 | 1991-09-17 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
US5034528A (en) * | 1988-07-27 | 1991-07-23 | North Carolina Central University | Compositions for the control of hyperlipidemia |
US5011947A (en) * | 1988-08-25 | 1991-04-30 | Bristol-Myers | Antihypercholesterolemic alkylene compounds |
US4920123A (en) * | 1988-10-21 | 1990-04-24 | Beyer Jr Karl H | Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
US5110817A (en) * | 1988-10-21 | 1992-05-05 | Beyer Jr Karl H | Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
US4920115A (en) * | 1988-12-28 | 1990-04-24 | Virginia Commonwealth University | Method of lowering LDL cholesterol in blood |
US5126145A (en) * | 1989-04-13 | 1992-06-30 | Upsher Smith Laboratories Inc | Controlled release tablet containing water soluble medicament |
US5002774A (en) * | 1989-06-08 | 1991-03-26 | Erbamont, Inc. | Sustained release pharmaceutical tablet |
US5010105A (en) * | 1989-06-09 | 1991-04-23 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
-
1992
- 1992-06-29 US US07/905,785 patent/US5268181A/en not_active Expired - Lifetime
-
1993
- 1993-06-29 EP EP93401681A patent/EP0577504B1/de not_active Expired - Lifetime
- 1993-06-29 DK DK93401681T patent/DK0577504T3/da active
- 1993-06-29 AT AT93401681T patent/ATE227128T1/de active
- 1993-06-29 EP EP02079607A patent/EP1310253A1/de not_active Withdrawn
- 1993-06-29 EP EP06006409A patent/EP1688143A3/de not_active Withdrawn
- 1993-06-29 PT PT93401681T patent/PT577504E/pt unknown
- 1993-06-29 ES ES93401681T patent/ES2186674T3/es not_active Expired - Lifetime
- 1993-06-29 DE DE69332463T patent/DE69332463T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0577504A1 (de) | 1994-01-05 |
EP1688143A3 (de) | 2009-11-11 |
EP1310253A1 (de) | 2003-05-14 |
DE69332463T2 (de) | 2003-07-10 |
DE69332463D1 (de) | 2002-12-12 |
US5268181A (en) | 1993-12-07 |
ES2186674T3 (es) | 2003-05-16 |
EP0577504B1 (de) | 2002-11-06 |
DK0577504T3 (da) | 2003-03-17 |
EP1688143A2 (de) | 2006-08-09 |
PT577504E (pt) | 2003-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE227128T1 (de) | Niacin enthaltende tabletten und sätze mit verzögerter wirkstoffabgabe | |
DK0751709T3 (da) | Anvendelse af Bcl-2 til fremstilling af lægemidler til terapeutisk behandling og forebyggelse af sygdomme | |
NO306235B1 (no) | Anvendelse av et legemiddel for behandling av artritt | |
DK0494972T3 (da) | Brusedosisform samt fremgangsmåde til administration heraf | |
NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
BR9507656A (pt) | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto | |
ZA926241B (en) | Dosage form for delivering drug in short-time period | |
GB9114363D0 (en) | Programmed release oral solid pharmaceutical dosage form | |
ITMI921325A1 (it) | Procedimento e dispositivo per il trattamento dell'obesita' di un paziente | |
FI901357A0 (fi) | Intraoralt medicingivarsystem. | |
NO933000D0 (no) | Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer | |
DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
EP0279887A3 (en) | Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder | |
LT97135A (en) | Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction | |
KR950010156B1 (en) | Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints | |
NO180450C (no) | Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin | |
AU1898792A (en) | Treatment or therapeutic booth for energetic, cosmetic and medical purposes | |
FR2677223B1 (fr) | Composition insecticide a base de rotenone, notamment pour le traitement des parasites humains et animaux. | |
IL117465A (en) | Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis | |
NO178283C (no) | Anordning for terapeutisk trykkbehandling | |
DK86093D0 (da) | Praeparat til medikamentel behandling for tandlaegebrug mod lidelserne tandkoedsbetaendelse og tandnervebetaendelse | |
Gilden | Thalidomide and aphthous ulcers | |
NO920031D0 (no) | Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat | |
GB9508938D0 (en) | Medication dosage reminder device | |
MX9710002A (es) | Nuevo uso medico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0577504 Country of ref document: EP |